Technology – retired

Our Smart-Blood Delivery Technology

Our technology is applied to three areas

Delivering neurotrophic factor across the blood-brain barrier to treat Alzheimer’s disease

Functionalized erythrocytes are designed to deliver anti-cancer agents specifically targeting prostate cancer

Erythrocyte-based nutraceuticals

We innovate based on scientific evidence

Hybrid erythrocyte liposomes: Functionalized red blood cell membranes for molecule encapsulation. Advanced Biosystems, 4(3), 1900185.

Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes. PLOS ONE, 17(3), p.e0263671.

Erythro-PmBs: A Specific Polymyxin B Delivery System Using Antibody-Conjugated Hybrid Erythrocyte Liposomes. ACS Infectious Diseases, 8(10), 2059-2072